UCL Institute of Neurology
- IoN HOME
- About the Institute
- Study Here
- Research Departments
- Research Groups and Themes A-Z
- Department of Brain Repair & Rehabilitation
- Department of Clinical and Experimental Epilepsy
- Department of Clinical Neuroscience
- Department of Molecular Neuroscience
- Department of Neurodegenerative Disease
- Department of Neuroinflammation
- Sobell Department of Motor Neuroscience and Movement Disorders
- Wellcome Trust Centre for Neuroimaging
- Clinical Divisions
- Services & Library
- Vacancies and PhDs
- National Hospital for Neurology and Neurosurgery
- Contact Us
- Staff Intranet
- IoN Directory
- Sources of support
- Cell Signalling Laboratory
- Diagnosis, prognosis and therapeutic monitoring in MS
- Experimental neuroinflammation
- Magnetic resonance physics
- Mechanisms of disability and recovery in MS
- MRI & pathology in MS
- MS Clinical Trial Unit
- Neuroimmunology Unit
- Neuropsychiatry Group: Brain abnormalities in psychosis
- NeuroResource Tissue Bank
- NMR Research Unit
- Queen Square MS Centre
Cannabis-mimicking MS drug trial starts
Publication date: 11 December 2015
A trial has started of a treatment that mimics the properties of cannabis to help reduce spasticity associated with multiple sclerosis (MS). The trial is being led by Dr Rachel Farrell, a consultant at the National Hospital for Neurology and Neurosurgery (UCLH) and Honorary Senior Lecturer at the UCL Institute of Neurology.
GABA neurotransmitter may be progressive MS marker
Publication date: 4 September 2015
A neurotransmitter widely distributed in the brain may be a marker of a progressive multiple sclerosis, according to research led by Professor Olga Ciccarelli, UCL Institute of Neurology, published in Brain.
Acute optic neuritis: a review and proposed protocol
Publication date: 14 July 2014
Optic neuritis is an inflammatory optic neuropathy that is frequently- but not always - associated with multiple sclerosis (MS). Despite recent developments in laboratory, imaging and electrophysiological techniques, no consensus guidelines have yet been formulated for the diagnostic work-up in patients presenting with optic neuritis.
Statins could help control MS
Publication date: 19 March 2014
Research published in the Lancet, led by Dr Jeremy Chataway (Honorary Senior Lecturer, UCL Institute of Neurology and Consultant Neurologist at the National Hospital for Neurology and Neurosurgery), has found that a high dose of the cholesterol-lowering drug simvastatin reduces the rate of brain shrinkage in people with secondary progressive multiple sclerosis (SPMS) by about 40% (the untreated rate is approximately 0.6% a year).
Imaging the evolution of multiple sclerosis
Publication date: 9 December 2011
Congratulations to Professor David Miller (Department of Neuroinflammation) who was the 2011 Raymond D Adams Memorial Lecturer at the Department of Neurology, Massachusetts General Hospital, Boston. He delivered this highly prestigious lecture, entitled “Imaging the evolution of multiple sclerosis”, on December 8th.
Elections to the Academy of Medical Sciences Fellowships announced
Publication date: 6 May 2010
Figures from UCL Neuroscience feature strongly in the newly announced elections to the Fellowship of the Academy of Medical Sciences.
Roads closed for powerful MRI scanner delivery
Publication date: 22 September 2009
Roads were closed in central London on Saturday as a new high-powered, six tonne MRI scanner was installed at the UCL Institute of Neurology in Queen Square.
Prestigious award for Professor David Miller
Publication date: 30 April 2009